Tony,
You are the one who made silly comment ...... just another expensive science experiment. I was only pointing out the validation study in real and full poultry grow cycle WAS REQUIRED ... for the regulatory pathway and to prove out ...... otherwise .... it is dead. The money has to be spent. No other option. You obviously think deals in pharma space happen quick. They don't ... plain and simple.
And yes fully aware of the $100 million joke in accumulated losses (much attributable to stock options and warrants) ... not really spent ... but won't get into those details ..... but yeah .... laughable fins tend to happen when original CEO was scam artist for about a decade ..... and next CEO a clueless know it all with no industry experience who delivered nothing. Um .... my disdain for both CEOs is well documented here. Dahl and his CFO should have been kicked 9 years ago.
You have been here long enough to know I have repeatedly mentioned this stock not being investable. Hence the reason folks like me and Weasel .... who posts our trades ..... swing trade this thing over and over again when the opportunity presents. Still holding buys at 60 cents after small sale to cover cost and then some as posted here. Looking for the next step from Payne.
Payne .... IS AN INDUSTRY VETERAN AT THE HIGHEST LEVELS .... and has been ZIVO CEO for just over 2 years. To reiterate he is the former CEO of Bayer Animal Health which today is Elanco and former CEO of Banfield (but according to you he don't know anyone).
ZIVOLife is in commercial production. Albeit nothing yet to write home about. Did Dahl make that happen ? Nope. The coccidiosis candidate has been talked about and tested for I'd have to say at least 6 or 7 years. Did Dahl make that happen ? Nope. In 2 years under Payne with Dahl getting the boot finally, algae is in commercial production, updated GRAS, has USDA jurisdiction and approval pathway confirmed instead of ridiculous FDA pathway, has at least 1 global animal health company looking at this and completed the primary and final tests in conjunction with .... which we know that they F&*("ED up. This repeat test took too long but validates the product in real world grow application. Things are going too slow, but the original test screwup isn't his doing.
Today, the company has those results in hand and USDA pathway ..... and can work the market for a license. Current non diluted market cap is just over $20 million. And what's the stock price if ... with 2.7 million shares out and I gather less than 1 million in float .....and a license is signed with Elanco, Merck or Zoetis. BTW ... you do recall ZIVO knows C Suite at Zoetis too right ? Bovine Mastitis ring a bell ?
Anyway .... interesting LII today. Literally no action but 100 shares at $8.50 offered which could be show .... but no offers above that til $10.90. Welcome to world of microcap low floaters. Maybe I should start playing with the MMs.
Amigo Mike
